Tolerability and discontinuation rates in teriflunomide-treated patients

From the Neurology Division (Alnajashi), Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, from the Department of Neurology (Alshamrani), Imam Abdulrahman Bin Faisal University, King Fahad Hospital of the University, Dammam, and from the Neurology Division (Freedman) Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, Canada

From the Neurology Division (Alnajashi), Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, from the Department of Neurology (Alshamrani), Imam Abdulrahman Bin Faisal University, King Fahad Hospital of the University, Dammam, and from the Neurology Division (Freedman) Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, Canada

From the Neurology Division (Alnajashi), Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, from the Department of Neurology (Alshamrani), Imam Abdulrahman Bin Faisal University, King Fahad Hospital of the University, Dammam, and from the Neurology Division (Freedman) Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, Canada